Tag: Cerulean Pharma

March 22, 2017

Cerulean Takes Hit Following Reverse Merger

Cerulean Pharma's stock went down after it announced its stock purchase agreement with Daré Bioscience.
March 19, 2017

5 Top NASDAQ Biotech Stocks: Cerulean Pharma gained 118.42 percent

Cerulean Pharma leads the list of last week's life science gainers on the NASDAQ, followed by Catalyst Pharmaceutical, Neovasc, Arbutus...
March 12, 2017

5 Top NASDAQ Biotech Stocks: Aurinia Pharmaceuticals Gained 76.72 percent

Here's a closer look at last week's top gainers.